Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1992;20:304-313

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bockman, C. S.
Right arrow Articles by Abel, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bockman, C. S.
Right arrow Articles by Abel, P. W.

Hypertension, Vol 20, 304-313, Copyright © 1992 by American Heart Association


ARTICLES

Enhanced release of endothelium-derived relaxing factor in mineralocorticoid hypertension

CS Bockman, WB Jeffries, WA Pettinger and PW Abel
Department of Pharmacology, Creighton University School of Medicine, Omaha, Neb. 68178.

Ring segments of superior mesenteric arteries studied in vitro were used to determine the role of the vascular endothelium in regulating vascular contractile and relaxant sensitivity in deoxycorticosterone acetate (DOCA)-salt hypertension. Wistar rats were given DOCA (20 mg/kg s.c. twice per week) and 1% NaCl drinking water for 5 weeks. In ring segments containing endothelium, there was a decrease in contractile sensitivity to arginine vasopressin, no change in contractile sensitivity to norepinephrine and KCl, and no change in relaxant sensitivity to acetylcholine or isoproterenol in arteries from hypertensive rats compared with normotensive controls. Removal of the vascular endothelium by rubbing had no effect on the contractile response to arginine vasopressin and KCl or the relaxant response to isoproterenol in control arteries. In arteries without endothelium, DOCA-salt hypertension caused a threefold increase in contractile sensitivity for arginine vasopressin, norepinephrine, and KCl; a 50% reduction in maximal relaxation to isoproterenol; and a threefold decrease in relaxant sensitivity to sodium nitroprusside. Indomethacin (10 microM) had no effect on contraction or relaxation. However, N- monomethyl L-arginine unmasked altered contractile sensitivity to norepinephrine in arteries from DOCA-salt hypertensive rats. These data show that the endothelium compensates for increased contractile and reduced relaxant responses of vascular muscle in DOCA-salt hypertension by increasing the release of endothelium-derived relaxing factor. These data suggest that altered vascular responsiveness is masked by the endothelium, thus preventing these alterations from contributing to increased peripheral resistance during the development of DOCA-salt hypertension.


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
F. Vargas, J. M. Moreno, R. Wangensteen, I. Rodriguez-Gomez, and J. Garcia-Estan
The endocrine system in chronic nitric oxide deficiency
Eur. J. Endocrinol., January 1, 2007; 156(1): 1 - 12.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Kobayashi, T. Matsumoto, K. Ooishi, and K. Kamata
Differential expression of {alpha}2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H135 - H148.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. W.F. Hadoke, C. Christy, Y. V. Kotelevtsev, B. C. Williams, C. J. Kenyon, J. R. Seckl, J. J. Mullins, and B. R. Walker
Endothelial Cell Dysfunction in Mice After Transgenic Knockout of Type 2, but Not Type 1, 11{beta}-Hydroxysteroid Dehydrogenase
Circulation, December 4, 2001; 104(23): 2832 - 2837.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. Guimaraes and D. Moura
Vascular Adrenoceptors: An Update
Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Alvarez, A. Osuna, R. Wangensteen, and F. Vargas
Interaction Between Nitric Oxide and Mineralocorticoids in the Long-Term Control of Blood Pressure
Hypertension, March 1, 2000; 35(3): 752 - 757.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. M. White, C. O. Rivera, and C. B. Davison
Differential Contribution of Endothelial Function to Vascular Reactivity in Conduit and Resistance Arteries From Deoxycorticosterone-Salt Hypertensive Rats
Hypertension, June 1, 1996; 27(6): 1245 - 1253.
[Abstract] [Full Text]


Home page
CirculationHome page
H. Makynen, M. Kahonen, X. Wu, P. Arvola, and I. Porsti
Endothelial Function in Deoxycorticosterone-NaCl Hypertension : Effect of Calcium Supplementation
Circulation, March 1, 1996; 93(5): 1000 - 1008.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Bonnardeaux, S. Nadaud, A. Charru, X. Jeunemaitre, P. Corvol, and F. Soubrier
Lack of Evidence for Linkage of the Endothelial Cell Nitric Oxide Synthase Gene to Essential Hypertension
Circulation, January 1, 1995; 91(1): 96 - 102.
[Abstract] [Full Text]